173 related articles for article (PubMed ID: 34804539)
1. virusMED: your travel guide to the virus world.
Coulibaly F
IUCrJ; 2021 Nov; 8(Pt 6):857-859. PubMed ID: 34804539
[TBL] [Abstract][Full Text] [Related]
2. virusMED: an atlas of hotspots of viral proteins.
Zhang H; Chen P; Ma H; Woińska M; Liu D; Cooper DR; Peng G; Peng Y; Deng L; Minor W; Zheng H
IUCrJ; 2021 Sep; 8(Pt 6):931-42. PubMed ID: 34614039
[TBL] [Abstract][Full Text] [Related]
3. Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors.
Jones JC; Kumar G; Barman S; Najera I; White SW; Webby RJ; Govorkova EA
mBio; 2018 Apr; 9(2):. PubMed ID: 29691337
[TBL] [Abstract][Full Text] [Related]
4. Current Strategies of Antiviral Drug Discovery for COVID-19.
Mei M; Tan X
Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
[TBL] [Abstract][Full Text] [Related]
5. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
6. Repurposing drugs targeting epidemic viruses.
Namasivayam V; Palaniappan S; Vanangamudi M
Drug Discov Today; 2022 Jul; 27(7):1874-1894. PubMed ID: 35427764
[TBL] [Abstract][Full Text] [Related]
7. Bridging the past and the future of virology: surface plasmon resonance as a powerful tool to investigate virus/host interactions.
Rusnati M; Chiodelli P; Bugatti A; Urbinati C
Crit Rev Microbiol; 2015 Jun; 41(2):238-60. PubMed ID: 24059853
[TBL] [Abstract][Full Text] [Related]
8. Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.
Gasparini R; Amicizia D; Lai PL; Bragazzi NL; Panatto D
J Prev Med Hyg; 2014 Dec; 55(4):109-29. PubMed ID: 26137785
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.
Becker Y
Virus Genes; 1994 Jul; 8(3):249-70. PubMed ID: 7975271
[TBL] [Abstract][Full Text] [Related]
10. Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug-target network analysis.
Rajput A; Thakur A; Rastogi A; Choudhury S; Kumar M
Comput Biol Med; 2021 Sep; 136():104677. PubMed ID: 34332351
[TBL] [Abstract][Full Text] [Related]
11. Know Your Enemy: Successful Bioinformatic Approaches to Predict Functional RNA Structures in Viral RNAs.
Lim CS; Brown CM
Front Microbiol; 2017; 8():2582. PubMed ID: 29354101
[TBL] [Abstract][Full Text] [Related]
12. Sequence- and interactome-based prediction of viral protein hotspots targeting host proteins: a case study for HIV Nef.
Sarmady M; Dampier W; Tozeren A
PLoS One; 2011; 6(6):e20735. PubMed ID: 21738584
[TBL] [Abstract][Full Text] [Related]
13. Using DrugBank for In Silico Drug Exploration and Discovery.
Wishart DS; Wu A
Curr Protoc Bioinformatics; 2016 Jun; 54():14.4.1-14.4.31. PubMed ID: 27322405
[TBL] [Abstract][Full Text] [Related]
14. Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe.
Pozo F; Lina B; Andrade HR; Enouf V; Kossyvakis A; Broberg E; Daniels R; Lackenby A; Meijer A;
J Clin Virol; 2013 May; 57(1):5-12. PubMed ID: 23375738
[TBL] [Abstract][Full Text] [Related]
15. Software Dedicated to Virus Sequence Analysis "Bioinformatics Goes Viral".
Hölzer M; Marz M
Adv Virus Res; 2017; 99():233-257. PubMed ID: 29029728
[TBL] [Abstract][Full Text] [Related]
16. Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approach.
Murugan NA; Kumar S; Jeyakanthan J; Srivastava V
Sci Rep; 2020 Nov; 10(1):19125. PubMed ID: 33154404
[TBL] [Abstract][Full Text] [Related]
17. Broadly neutralizing antibodies recognizing different antigenic epitopes act synergistically against the influenza B virus.
Zhai L; Zhang L; Jiang Y; Li B; Yang M; Victorovich KV; Aleksandrovna KT; Li M; Wang Y; Huang D; Zeng Z; Ren Z; Cao H; Zhu L; Wu Q; Xiao W; Zhang B; Wan C; Wang F; Xia N; Zhao W; Chen Y; Shen C
J Med Virol; 2023 Jan; 95(1):e28106. PubMed ID: 36039848
[TBL] [Abstract][Full Text] [Related]
18. Host Synthesized Carbohydrate Antigens on Viral Glycoproteins as "Achilles' Heel" of Viruses Contributing to Anti-Viral Immune Protection.
Galili U
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933166
[TBL] [Abstract][Full Text] [Related]
19. DRAVP: A Comprehensive Database of Antiviral Peptides and Proteins.
Liu Y; Zhu Y; Sun X; Ma T; Lao X; Zheng H
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112801
[TBL] [Abstract][Full Text] [Related]
20. Network-Guided Discovery of Influenza Virus Replication Host Factors.
Ackerman EE; Kawakami E; Katoh M; Watanabe T; Watanabe S; Tomita Y; Lopes TJ; Matsuoka Y; Kitano H; Shoemaker JE; Kawaoka Y
mBio; 2018 Dec; 9(6):. PubMed ID: 30563907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
